Colorectal Cancer Is Climbing in Teens, Study Finds

Colorectal cancer is climbing in adolescents, and a new analysis presented at the American Academy of Pediatrics' national conference in San Diego in early October 2026 suggests the disease behaves far more aggressively in young patients than in older adults. The retrospective study reviewed the records of 84 patients aged 21 or younger who were diagnosed between 2012 and 2023 at 34 institutions, and found that the vast majority arrived with late-stage disease. Only about one in five had a first- or second-degree relative with colorectal cancer, leaving most cases without the family-history warning flag that normally prompts earlier screening, according to the conference press release carried by Medical Xpress.

What makes the analysis unusual is who it left out. The researchers excluded anyone with a known colorectal cancer predisposition syndrome or inflammatory bowel disease, so the cancers studied were largely sporadic cases in young people with no identifiable inherited risk. The median age at diagnosis was just sixteen and a half, and more than half of the patients were male. Roughly three quarters of the tumors were colon cancers and the rest rectal cancers, with the sigmoid and ascending colon the most common sites and a handful of unusually rare appendiceal tumors in the mix, as reported by Bioengineer.

Most colorectal cancer in teens is found late

By the time doctors made a diagnosis, the disease had usually advanced. About half of the patients presented with stage III disease and nearly three in ten with stage IV metastatic disease, meaning roughly four in five arrived with locally advanced or metastatic cancer. The tumor biology matched the aggressive picture: about a third of the tumors showed signet ring features, nearly two in five produced mucin, and more than two in five were poorly differentiated, all markers of harder-to-treat disease that tends to spread faster.

Why warning signs get missed

The symptom profile reads like a list of complaints most teenagers shrug off. Back or abdominal pain was the most common symptom, reported by nearly three quarters of patients, followed by changes in bowel habits, weight loss, and rectal bleeding. Each of these can be blamed on constipation, diet, stress, sports injuries, or hemorrhoids, and the study measured the cost of that misattribution: symptoms lingered for a median of three months before diagnosis, and the typical wait for a colonoscopy stretched even longer. Because colorectal cancer is rare in young people, clinicians often do not have it on their radar, and families may not push for answers.

Family history did not fill the gap either. In older adults, a relative with the disease is one of the main triggers for earlier and more frequent colorectal cancer screening, but that early-warning signal was missing for the great majority of these young patients. Routine screening was never on the table for them: they were far below the ages the guidelines cover, even after the US Preventive Services Task Force lowered the recommended starting age from 50 to 45 in 2021 in response to rising early-onset cases; deaths among people under 55 had been climbing about one percent a year for more than a decade, as reported by UChicago Medicine.

What young people should know about colorectal cancer

The outcomes were sobering. More than a third of the patients saw their cancer return, typically within about a year of treatment, and nearly all of those relapses happened in patients first diagnosed with stage III or IV disease. Relapse was far more likely when lymph nodes tested positive at diagnosis or when tumors were poorly differentiated or showed signet ring features, and even patients who received chemotherapy after surgery were not spared. By the end of the study period, nearly half of the young patients had died from the disease.

Genetic testing added another layer. Just over half of the patients were tested for inherited mutations, and among those tested, a meaningful share carried mutations in mismatch repair genes, the TP53 gene, or the APC gene, despite having no known predisposition syndrome when diagnosed. The researchers say the finding supports broader genetic evaluation in young-onset colorectal cancer and testing of relatives when mutations turn up.

The study's authors stop short of calling for new screening rules for teenagers. Instead, they argue that the findings demand a change in clinical mindset, as reported by Bioengineer. Pediatricians and other clinicians should keep colorectal cancer in mind when an adolescent shows up with persistent abdominal or back pain, altered bowel habits, unexplained weight loss, or rectal bleeding that has no other explanation. For families, the takeaway is practical: symptoms like these deserve a serious workup, not a wait-and-see approach.

Study author Erica Arnold, a pediatric surgery research fellow, put it directly: the disease is "becoming more common in adolescents and young adults" and behaves as "a different disease" than the colorectal cancer seen in older adults. When it is found, she noted, it tends to arrive aggressive and late, with high rates of relapse and death, according to remarks published by Medical Xpress.

For more reporting on the health issues hitting young people hardest, visit our health topic page.

Related: researchers are also launching new efforts to understand the rise, including a large study recruiting young adults to find answers on bowel cancer in young adults.